Season 5 of the National Museum of Racing and Hall of Fame’s popular live webcam series Foal Patrol is now available online at www.foalpatrol.com. Foal Patrol is a one-of-a-kind collection of live cameras following the daily activities of in-foal mares produced by the National Museum of Racing. Millions of people throughout the world have viewed the popular webcam program since its inaugural season in 2018.
Month: January 2022
First Foal a Filly For GISW Win Win Win
Ocala Stud's Win Win Win (Hat Trick {Jpn}–Miss Smarty Pants, by Smarty Jones), winner of the GI Forego S. in 2020, was represented by his first foal when the Vindication mare Famous produced a filly at the Florida nursery Jan. 2.
“We are ecstatic about Win Win Win's first foal,” said Ocala Stud's David O'Farrell. “She is grand-looking, just like her sire.”
The bay is the sixth produce for her dam who has already been responsible for Grade III-placed juvenile filly Courteous (Midnight Lute). Famous is a daughter of GSW Statuette (Pancho Villa), making her a half-sister to Irish highweight Tomahawk (Seattle Slew). This is the extended Peter Blum family of GISW Well Chosen (Deputy Minister) and GSWs Academy Award (Secretariat) and Good Mood (Devil's Bag).
The post First Foal a Filly For GISW Win Win Win appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.
Zarak Share to Be Offered at Arqana Online
A 1/50th share in young sire Zarak (Fr) will be offered as lot 1 in the upcoming Arqana Online January Sale. Slated for Jan. 13 from 3-5 p.m. French time, the sale also features a breeding right in Territories (Ire) (lot 2); a half-share (1/100th) in Al Wukair (Fr) (lot 3); the listed placed broodmare Becquascenthe (Fr) (Nombre Premier {GB}) (lot 4); and a trio of National Hunt horses-in-training.
His Highness The Aga Khan's Zarak was the leading first-season sire in France in 2021, and among his 18 2-year-old winners were the Group 1-placed Times Square (Fr) and Purplepay (Fr), the latter a €2-million buy in the Arqana ring who is bound for America. The son of Dubawi (Ire) and the Arc heroine Zarkava (Ire) also has Group 3 winner Lizaid (Ger). He is fully booked at €25,000 at Haras de Bonneval this term.
Territories already is the sire of G1 Prix de l'Opera heroine Rougir (Fr), who brought a sale-topping €3 million at Arqana in December. He stands at Dalham Hall Stud for £10,000 in 2022, while Al Wukair has 15 juvenile winners, so far. The Group 1 winner is priced at €8,000 at Haras de Bouquetot.
Becquascenthe, a half-sister to Grade 1 winner Grande Haya (Fr) (Solid Illusion) is offered in foal to Doctor Dino (Fr).
The post Zarak Share to Be Offered at Arqana Online appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.
Are There Any Disadvantages To Popular PPID Treatment?
Pituitary Pars Intermedia Dysfunction (PPID or Cushing's disease) is a disease that affects many older horses, but it can often be controlled with the use of a medication called Pergolide.
In other parts of the world, Pergolide is used in human medicine to combat the symptoms of Parkinson's disease, restless leg syndrome, and hyperprolactinemia. Side effects can include fibrotic lesions of the atrioventricular valves in the heart.
Dr. Heidrun Gehlen, from the Department of Veterinary Medicine at the Free University of Berlin, gathered a team of scientists to determine whether the same effects would be seen in horses.
The scientists examined 23 horses between 19 and 30 years old, all of which had been diagnosed with PPID using the ACTH adrenocorticotrophin hormone test. The treatment group comprised 12 horses that had been receiving Pergolide for between 14 days and 6 years, while 11 other horses in the control group received no Pergolide.
The researchers performed an echocardiographic exam on all horses, and found that each was free of cardiovascular disease; no valve defects were found.
[Story Continues Below]
Follow-up exams were then given to nine horses in the treatment group and five in the control group between three and eight months later. The findings were the same: use of Pergolide did not affect ventricular function or cause valve disease in horses.
Read more at Equine Science Update.
The post Are There Any Disadvantages To Popular PPID Treatment? appeared first on Horse Racing News | Paulick Report.
